A mass on the shin
暂无分享,去创建一个
[1] P. Gisondi,et al. European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] Daniel B. Shin,et al. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network. , 2016, JAMA dermatology.
[3] A. Nast,et al. Methods Report: European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – update 2015 – EDF in cooperation with EADV and IPC , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] P. Gisondi,et al. European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] A. Kreuter,et al. 2013 European guideline on the management of lymphogranuloma venereum , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] L. Dubertret,et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. , 2003, The Journal of investigative dermatology.